Spots Global Cancer Trial Database for cd20 ,follicular lymphoma,marginal zone lymphoma,mil62
Every month we try and update this database with for cd20 ,follicular lymphoma,marginal zone lymphoma,mil62 cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) | NCT04110301 | Follicular Lymp... | Recombinant Hum... Lenalidomide | 18 Years - | Beijing Mabworks Biotech Co., Ltd. | |
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) | NCT04110301 | Follicular Lymp... | Recombinant Hum... Lenalidomide | 18 Years - | Beijing Mabworks Biotech Co., Ltd. | |
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) | NCT04110301 | Follicular Lymp... | Recombinant Hum... Lenalidomide | 18 Years - | Beijing Mabworks Biotech Co., Ltd. | |
MIL62 Plus Lenalidomide for Patients With Relapsed/Refractory Indolent Non-Hodgkin's Lymphoma (FL and MZL) | NCT04110301 | Follicular Lymp... | Recombinant Hum... Lenalidomide | 18 Years - | Beijing Mabworks Biotech Co., Ltd. |